NDC 70602-005

Exoden Cavity

Silicon Dioxide, Aluminum Chlorohydroxy Allantoinate, Sodium Monofluorophosphate

Exoden Cavity is a Topical Paste in the Human Otc Drug category. It is labeled and distributed by Lifeon Corp.. The primary component is Alcloxa; Silicon Dioxide; Sodium Monofluorophosphate.

Product ID70602-005_bd39f80a-f7cb-4fae-e053-2a95a90a08d7
NDC70602-005
Product TypeHuman Otc Drug
Proprietary NameExoden Cavity
Generic NameSilicon Dioxide, Aluminum Chlorohydroxy Allantoinate, Sodium Monofluorophosphate
Dosage FormPaste
Route of AdministrationTOPICAL
Marketing Start Date2021-03-10
Marketing CategoryUNAPPROVED DRUG OTHER /
Labeler NameLIFEON Corp.
Substance NameALCLOXA; SILICON DIOXIDE; SODIUM MONOFLUOROPHOSPHATE
Active Ingredient Strength0 g/100g; g/100g; g/100g
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 70602-005-02

1 TUBE in 1 CARTON (70602-005-02) > 120 g in 1 TUBE (70602-005-01)
Marketing Start Date2021-03-10
NDC Exclude FlagN
Sample Package?N

Drug Details


© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.